COMBINATIONS OF KINASE INHIBITORS FOR THE TREATMENT OF CANCER
摘要
The present invention provides methods of treating cancer by administering a compound of formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with an inhibitor that targets HER2 and/or HER3.